Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Nasopharyngeal Carcinoma 2Rectal Neoplasms 1Nasopharyngeal Neoplasms 1Lung Neoplasms 1Esophagitis 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Burkitt Lymphoma 1Anus Neoplasms 1

Interventions

Radiotherapy 4pembrolizumab 2aldesleukin 2Specimen Handling 2Radiation 2Mitomycin 2Drug Therapy 2Capecitabine 2Adoptive Transfer 2trastuzumab deruxtecan 1spartalizumab 1fludarabine 1Tomography, X-Ray Computed 1Surveys and Questionnaires 1Restraint, Physical 1Radiotherapy, Intensity-Modulated 1Positron-Emission Tomography 1Parturition 1Paclitaxel 1Nivolumab 1Magnetic Resonance Spectroscopy 1Induction Chemotherapy 1Immune Checkpoint Inhibitors 1Human Papillomavirus DNA Tests 1Fluorouracil 1Fluorodeoxyglucose F18 1FAPI-46 1Diagnostic Tests, Routine 1Dehydroepiandrosterone 1Cytological Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Anus Neoplasms × Induction Chemotherapy × Clear all
NCT06207981 2025-09-02

KANALRAD

Federation Francophone de Cancerologie Digestive

Phase 3 Recruiting
310 enrolled
Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡